A000225 Stock Overview

Develops and markets pharmaceutical products. More details

A000225 fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	2/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 97.8% below our estimate of its fair value

Became profitable this year

Risk Analysis

Large one-off items impacting financial results

Volatile share price over the past 3 months compared to the KR market

Does not have a meaningful market cap (₩75B)

My Notes

Capture your thoughts, links and company narrative

Yuyu Pharma, Inc. Competitors

JW Shinyak

KOSDAQ:A067290

₩77.8b

Sinil Pharmaceutical

KOSDAQ:A012790

₩73.6b

Sinsin Pharmaceutical

KOSDAQ:A002800

₩78.7b

Ahn-Gook Pharmaceutical

KOSDAQ:A001540

₩72.9b

Price History & Performance

Summary of share price highs, lows and changes for Yuyu Pharma
Historical stock prices
Current Share Price	₩4,785.00
52 Week High	₩6,130.00
52 Week Low	₩4,045.00
Beta	0.50
1 Month Change	1.06%
3 Month Change	-4.11%
1 Year Change	-17.36%
3 Year Change	-58.21%
5 Year Change	17.42%
Change since IPO	292.21%

Recent updates

Shareholder Returns

	A000225	KR Pharmaceuticals	KR Market
7D	2.2%	5.7%	2.7%
1Y	-17.4%	11.9%	-5.9%

Return vs Industry: A000225 underperformed the KR Pharmaceuticals industry which returned 11.9% over the past year.

Return vs Market: A000225 underperformed the KR Market which returned -5.9% over the past year.

Price Volatility

Is A000225's price volatile compared to industry and market?
A000225 volatility
A000225 Average Weekly Movement	11.2%
Pharmaceuticals Industry Average Movement	5.6%
Market Average Movement	6.8%
10% most volatile stocks in KR Market	13.0%
10% least volatile stocks in KR Market	3.4%

Stable Share Price: A000225's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A000225's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

Founded	Employees	CEO	Website
1941	253	Robert Yu	www.yuyu.co.kr

Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Jecheon-si, South Korea.

Yuyu Pharma, Inc. Fundamentals Summary

How do Yuyu Pharma's earnings and revenue compare to its market cap?
A000225 fundamental statistics
Market cap	₩75.25b
Earnings (TTM)	₩8.56b
Revenue (TTM)	₩134.79b

8.8x

P/E Ratio

0.6x

P/S Ratio

Is A000225 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A000225 income statement (TTM)
Revenue	₩134.79b
Cost of Revenue	₩83.69b
Gross Profit	₩51.10b
Other Expenses	₩42.55b
Earnings	₩8.56b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	528.76
Gross Margin	37.91%
Net Profit Margin	6.35%
Debt/Equity Ratio	26.4%

How did A000225 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/12 22:35
End of Day Share Price	2025/02/12 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Yuyu Pharma, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Hyung Soo Kim	Cape Investment & Securities Co., Ltd.